ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

MITRE Names New Chief Technology Officer and Corporate Chief Engineer

Seasoned Senior Vice Presidents Assume New Roles; Charles Clancy Named Chief Technology Officer, and Jay Schnitzer Named Corporate Chief Engineer

MITRE’s Charles Clancy, Ph.D., was named chief technology officer in addition to his role as senior vice president and general manager of MITRE Labs. He assumes management of the MITRE independent research and development (IR&D) program. Across these integrated responsibilities, Clancy leads MITRE’s science, technology, and engineering workforce, the IR&D program, and extramural research activities. Dr. Jay Schnitzer, MITRE’s senior vice president and chief medical officer, was named corporate chief engineer. He will help assure MITRE-wide technical quality and mission impact, support technical staff development, and continue as chief medical officer.

“Science and technology are critical to our nation’s future in an era of global strategic competition,” said Jason Providakes, Ph.D., MITRE president and CEO. “Charles will leverage MITRE’s research activities to drive whole-of-nation impacts across MITRE’s work with sponsors and partners in industry, academia, and other non-profit organizations. Jay will ensure our work meets the high bar of technical excellence needed to help our federal sponsors succeed in their missions and will continue to advance our cancer and quantum computing R&D programs.”

Clancy joined MITRE in 2019 as the vice president for intelligence programs and was promoted to lead MITRE Labs in 2020. He previously served as the Bradley Distinguished Professor of Cybersecurity in the department of electrical and computer engineering at Virginia Tech, and earlier as a research leader at the National Security Agency. In 2022 he was named a fellow of the Institute for Electrical and Electronics Engineers for his work in secure and wireless communications.

Schnitzer joined MITRE in 2013 and has served as the company’s chief technology officer for the past eight years. He previously led DARPA’s defense sciences office, was Boston Scientific’s chief medical officer, and worked over 15 years as an attending pediatric surgeon and associate professor of surgery at Massachusetts General Hospital, Shriners Children’s Hospital Boston, and Harvard Medical School. He received the WashingtonExec 2020 Healthcare Industry Executive of the Year award for his work leading the COVID-19 Healthcare Coalition and was named to FCW’s Fed 100 in 2023.

About MITRE

MITRE’s mission-driven teams are dedicated to solving problems for a safer world. Through our public-private partnerships and federally funded R&D centers, we work across government and in partnership with industry to tackle challenges to the safety, stability, and well-being of our nation. Learn more at mitre.org.

Contacts

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.